INTRODUCTION
Assisted reproductive techniques have become well-accepted methods for the treatment of infertile couples. Although they are practiced widely almost everywhere in the world, a debate regarding their efficacy, cost/effectiveness, risk factors, and side effects still exists.
Ultrasonographic guided vaginal oocyte recovery is a relatively atraumatic method with rare complications. Since Wickland (1) first described the technique, it was rapidly accepted and spread becoming the method of choice in most IVF programs. Transvaginal ovum pick-up has proven to be efficient (high recovery rate of good quality oocytes) with minimal discomfort for patients in large reported IVF series. Furthermore, this procedure allows the use of local anesthesia with sedation, is rapid and easy to perform, decreases the cost to the patient, and permits a quick postoperative recovery. Nevertheless, despite the advantages, the aspiration needle may injure the adjacent pelvic organs and structures inducing serious, and sometimes even fatal, complications: vaginal wall hemorrhage (2) , hemoperitoneum because of ovarian or pelvic blood vessel lesions (3) (4) (5) , infection or exacerbation of pelvic inflammatory diseases (6) , rupture of endometriotic cystic masses, urinary tract infections, or ureteral lesions (7).
The case we present here describes a hemoperitoneum in which, at laparotomy, it was not possible to observe a direct damage of any blood vessel. However, retrospectively, a deficit of coagulation factor XI was shown.
CASE REPORT
V.F., a 34-year-old woman with a history (13 years) of primary infertility due to the partner anejaculation resulting from a spinal cord injury, was referred to our Infertility Clinic in May 1998.
The patient had regular menstrual cycles (28 ± 2 days) and patent tubes on X-ray hysterosalpingography. Previous hormonal and ultrasonographic (US) evaluations confirmed ovulatory cycles. The woman had not received hormonal treatment in the previous 6 months nor anticoagulants in the past. History, apart from two menorrhagic episodes in the past, did not reveal a hemorrhagic tendency (prolonged bleeding after minor injuries). Her partner in the diagnostic electroejaculation presented severe oligospermia associated with significant degrees of astheno-and terato-spermia according to World Health Organization standards. The couple underwent rectal probe electroejaculation and intracytoplasmic sperm injection.
Controlled ovarian hyperstimulation (COH), briefly, was achieved by an injection on day 20 of the cycle of i.m. gonadotropin-releasing hormone agonist (Decapeptyl 3.75; Ipsen, Milan, Italy) and pure FSH (pFSH) (Metrodin HP; Serono, Rome, Italy) administered i.m. (225 IU/day during the first three days of stimulation and 150 IU/day thereafter) after pituitary desensitization (plasma estradiol <100 pmol/l; ovaries with no follicles >5 mm in diameter and endometrial thickness <5 mm). When more than three follicles of >17 mm in diameter were present, Metrodin HP was withdrawn and 10,000 IU human chorionic gonadotropin (hCG; Profasi; Serono) was administered i.m.
US (AU 4 Idea scanner with 6.5 MHz vaginal transducer; Esaote, Milan, Italy) transvaginal oocyte recovery was performed 35 h after the hCG injection was given. The procedure was performed by an experienced reproductive surgeon (C.B.). The transvaginal probe was draped with a gas-sterilized bag, and a sterile biopsy guide was affixed. The follicles were aspirated with a fine needle (18 G) and 180 mmHg suction pressure. Puncture was started in the ovary with the follicles closest to the lateral fornix of the vagina, and each follicle was sequentially punctured without reinserting the needle through the vaginal wall. The same technique was used for the controlateral ovary. Follicles were not flushed, and no heavily blood-stained aspirates were observed. Ten oocytes were retrieved. At the end of the procedure, as routinely done, the pelvis was ultrasonographically inspected for any sign of bleeding from the iliac vessels or the ovary, and the patient was kept in the ward for observation.
Electroejaculation was performed by using the rectal-probe electrode developed by Seagar and reported by Bennett et al. (8) . The site of injury was below T-10. Thus sublingual nifedipine administration, to avoid autonomic dysreflexia, and general anesthesia were not carried out. The patient was placed in the lateral decubitus position, and a 31-mm diameter probe was inserted in the rectum. Stimulation was started at 10 V, and each stimulation lasted 2-4 s. Three stimulations (maximum voltage 15 V) necessary to obtain an anterograde ejaculation resulted. Retrograde ejaculate was retrieved by the catheterization of the bladder at the end of stimulation. The sample presented 5 × 10 6 total spermatozoa with ≈1% progressive motility.
The preparation of spermatozoa and oocytes, setting for microinjection, and ICSI procedure were performed as described by Palermo et al. (9) Nine embryos were obtained. Because of the subsequent events, no embryos were transferred, and 5 cleaved embryos with <20% fragmentation were allocated to a cryopreservation protocol. After 6 months, three thawed embryos were replaced. Transcervical transfer was carried out using a Fryedman catheter (SCS International, Genoa, Italy). No pregnancy took place.
Three hours after ovum pick-up, the patient suffered from a lipothymic episode. Her hemoglobin was 10.4 g/dl, and the hematocrit was 29.3%. No US significant signs of pelvic hemorrhage were found. In the subsequent 2 h, the hemoglobin fell to 8.2 g/dl, the hematocrit to 23.7%, and an abdomen rebound defance increased progressively. In the pelvis, ≈250 ml of floating blood was evidenced both by transvaginal and transabdominal ultrasonography. Exploratory laparotomy did not find any wall lesion of pelvic vessels. However, a diffuse blood leakage from the surface of both ovaries was observed. Drainage of the pelvic blood, partial resection of stuffed ovaries, and accurate hemostasis, essential operative procedures for stopping hemorrhage, resulted. The patient was discharged from the hospital after 10 days, the hemoglobin being 9.6 g/dl and hematocrit being 28.1%.
Retrospectively, on −20
• frozen plasma, we analyzed the patient's hematological parameter prior to COH, and no specific alterations of screening coagulation tests, apart from an isolated mild prolongation (ratio = 1.31; normal range = 0.82-1.24) of the activated partial thromboplastin time, were found. Because of this, we further assayed the activity of coagulation factors VIII, IX, XI, and XII (Dade Behring, Milan, Italy), by using a Behring coagulation chromotimer (Dade Behring). The chromotimer automatically calculated the results in percent of normality showing a slight decrease of coagulation factor XII (51%; normal range = 60%-150%), and a more evident decrease of coagulation factor XI (39%; normal range = 60%-150%).
DISCUSSION
Ovum pick-up by transvaginal route has been heralded as an important progress for assisted reproduction technologies. Although transvaginal oocyte recovery has to be considered safer than the original laparoscopic approach, the injuries due to the aspiration needle may be responsible for mild to severe complications.
Low quantity vaginal hemorrhage is one of the most common consequence of transvaginal oocyte aspiration. It appears in 1.4%-18.4% of all punctures and is susceptible to local treatment such as application of pressure or topical haemostatic agents or both or suture of the lesion (3). On the other hand, intraabdominal bleeding presents an incidence of 0.07%-0.08% (2, 4) . Hemoperitoneum may occur from direct damage to pelvic organs (uterus, bladder, bowels) or to pelvic blood vessels erroneously interpreted as intraovarian follicles. Serious cases of iliac vessels lesions, requiring laparoscopy or emergency laparotomy, have been described by Bergh and Lundkvist (10) .
In the case that we presented, no evidence, at laparotomic exploration, of iatrogenic damage of pelvic structures have been observed, and the clinical evolution allowed the exclusion of acute and massive bleeding related with vessel lesions. Hemoperitoneum may also occur as the result of bleeding of small intrafollicular vessels during the flushing of the follicular bed with solutions containing heparin (4). However, the choice, in the reported case, of not flushing the follicles allow the exclusion of such a hypothesis. In addition, the absence of heavily blood-stained aspirates also permit the exclusion of a damage of the fine vascularization of theca interna layer.
Cessation of bleeding requires the interaction of a damaged blood vessel with the circulating clotting proteins and platelets to form a stable platelet-fibrin plug. Abnormalities of any of these factors, either inherited or acquired, may result in clinically significant bleeding.
The presence of a congenital coagulation disorder may be suspected because of a positive family history, occurrence of unusual bleeding, or the serendipitous finding of an abnormal screening coagulation test. The isolated prolongation of the activated partial thromboplastin time may be typical of contact factor (factor XI and XII, kininogen, prekallikrein) deficiencies (11) . However, the diagnosis of any inherited or acquired coagulation deficiency has to be confirmed by specific factor analysis. In the present case, a slight decrease of coagulation factor XII and a more evident decrease of coagulation factor XI has been found. Factor XII deficiency is transmitted as an autosomal characteristic, is fully expressed in homozygotes, and most affected individuals are absolutely asymptomatic or, rarely, may have only a very mild tendency to bleed (12) . Factor XI deficiency is inherited as an autosomal trait and occurs, both in homozygous and heterozygous forms, mainly in Ashkenazi descents (13) . The bleeding diathesis does not always relate with the circulating levels of factor XI coagulant protein and is variable among individuals in response to different hemostatic challenges (14). In general, when present, symptoms include easy bruising, epistaxis, menorrhagia, and post surgical or traumatic hemorrhage (15). On the basis of these considerations, we speculated that in our own patients, the minimal needle traumas triggered a heavy blood leakage because of a partial deficiency of coagulation factor XI.
CONCLUSIONS
Although, most complications of transvaginal ovum pick-up are mild, severe life-threatening hemorrhagic complications may rarely occur. To further reduce their occurrence and severity we suggest a specific attention to the screening coagulation tests, a sequential follicular aspiration without reinserting the needle through the vaginal wall, and that the patient be kept in the ward for observation for at least 4 h.
INTRODUCTION
Increasing numbers of women achieve long-term survival following the diagnosis of cancer. Improvements in chemo-and radiotherapy have altered the clinical course and outcome of many malignancies once considered terminal. For instance, advances in the treatment of all stages of Hodgkin's disease have resulted in long-term survival in more than 70% of patients (1) . The number of survivors of childhood or 1 Presented at the 47th Annual Meeting of the American College of Obstetrics and Gynecology, Philadelphia, Pennsylvania. adolescent cancer is substantial and rising as contemporary techniques for treating disease improve. As a result, many women of reproductive age are now able to conceive spontaneously and carry pregnancies despite their prior diagnosis. However, in other cases, following cancer treatment, ovarian function may be lost or compromised, and reliance on assisted reproductive techniques is required. These women are able to achieve pregnancy through oocyte donation.
Missing from most reports is the follow-up of women treated with assisted reproductive techniques. We report the result of 10-year work with cancer patients attempting oocyte donation for treatment of their infertility. Included are reproductive, neonatal, and medical follow-up experiences.
MATERIALS AND METHODS
The method of oocyte and embryo donation has previously been described (2) . Protocols used were reviewed and approved by both the Institutional Review Board (IRB) of the California Medical Center, Los Angeles, CA (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) , and the IRB of Columbia-Presbyterian Medical Center, New York, NY (1995) (1996) (1997) . Oocyte donors and recipients were screened medically, reproductively, and psychologically. Donors received gonadotropin releasing hormone agonist (GnRH-a) to produce a castrate state and ovarian hyperstimulation with menotropins. Oocytes were retrieved transvaginally by ultrasoundguided needle aspiration and fertilized in vitro. Embryos were transferred at 48 or 72 h postaspiration.
Recipients received a combination of sequentially administered estrogen and progesterone to prepare the uterus for embryo transfer (3). Prior to initiating the actual attempt at oocyte donation, endometrial biopsies documented a progestational lining during a mock cycle in which samples were taken on day 21 of hormone replacement.
Oncologists were consulted prior to initiating therapy. A second opinion was also obtained from an independent oncologist, in addition to the patient's primary care provider. Additional opinions were felt to be particularly important for cases where disease states were known to be in remission, but not cured. All patients were believed by oncologists to be disease free, and without significant risk of recurrence.
Psychiatric Consultation was also required. Evaluation of the patient's emotional and psychosocial supports was considered mandatory. Patients commonly
